{"id":52317,"date":"2022-12-23T01:02:32","date_gmt":"2022-12-23T00:02:32","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/"},"modified":"2022-12-23T01:02:32","modified_gmt":"2022-12-23T00:02:32","slug":"vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/","title":{"rendered":"Vicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System"},"content":{"rendered":"
\n

WALTHAM, Mass.–(BUSINESS WIRE)–Vicarious Surgical Inc. (\u201cVicarious Surgical\u201d or the \u201cCompany\u201d), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, hosted the first public demonstration of its Beta 2 surgical robotic platform on December 6, 2022, highlighting the latest evolution of its differentiated technology and showcasing recent cadaveric testing. Supporting presentations by representatives from leading healthcare provider University Hospitals and renowned surgeon Dr. Igor Belyansky outlined the extensive opportunity for Vicarious to address current shortcomings in surgical robotics at the system and user level.\n<\/p>\n

<\/a><\/p>\n

\n\u201cThe finalization of our Beta 2 surgical platform is the culmination of years of hard work and marks an important milestone in our development pathway,\u201d said Adam Sachs, CEO and co-founder of Vicarious Surgical. \u201cI\u2019d like to thank our employees, as well as our hospital system and surgeon partners for their contributions to this achievement. We look forward to further evolving the Beta 2 platform into our initial product offering.\u201d\n<\/p>\n

\nAs part of the Beta 2 Demonstration Day event, Dr. Belyansky reviewed intra-operative video of his recent cadaveric ventral hernia repair procedures in which he utilized the Vicarious Surgical Beta 2 system.\n<\/p>\n

\nLink to cadaveric procedural videos<\/a>\n<\/p>\n

\nBelyansky, MD, Chief of General Surgery at Anne Arundel Medical Center in Annapolis, has particular research interest in quality of life outcomes after hernia surgery. He is a co-investigator of several research grants and has authored 16 publications, six book chapters, and several invited commentaries. He frequently presents at national and international surgical meetings and has received numerous research related awards. He also leads Vicarious Surgical\u2019s twenty-person Surgeon Luminary Group, providing expertise and leadership to guide all clinical aspects of the Vicarious Surgical technology.\n<\/p>\n

\n\u201cI am continually impressed with Vicarious\u2019 acute focus on surgeon needs; the Beta 2 system showcased numerous differentiating capabilities, such as dynamic port placement, simple docking, dexterous instrumentation, and full access and visualization, that are attractive to surgeons such as myself,\u201d said Belyansky. \u201cI was extremely encouraged by my experience with the Beta 2 system and what this technology means for the future of robotic surgery.\u201d\n<\/p>\n

\nFrom the Company\u2019s Center of Excellence collaborator, University Hospital Ventures, representatives David Sylvan, President of UH Ventures, and Kendra Gardiner, Director of Product Strategy, outlined UH Ventures\u2019 history of innovation and aspirations to shape the future of surgical robotics through its work with Vicarious Surgical. UH Ventures detailed hospital system data exemplifying and explaining the largest unmet needs of surgeons and hospital systems to date.\n<\/p>\n

\n\u201cAcross University Hospitals, we see a significant opportunity to convert current open and laparoscopic procedures to a less invasive approach. To do this, however, we know we must continue sourcing and embracing potentially disruptive innovations in the robotic-assisted surgery space,\u201d said David Sylvan, President of UH Ventures. \u201cThe results of the Beta 2 cadaveric testing and the strong positive reaction of our constituents reaffirms our commitment to innovation in surgical robotics and our collaboration with Vicarious Surgical to deliver differentiated surgical platforms to enhance patient care and clinical outcomes.\u201d\n<\/p>\n

\nUniversity Hospitals Ventures and Vicarious Surgical entered a collaborative Center of Excellence (\u201cCOE\u201d) agreement in June 2022 with the shared goal of improving the landscape for minimally invasive surgery that enhances patient care and clinical outcomes. Through the collaboration, Vicarious Surgical gains unique exposure to the detailed surgical workflows of the hospital system and incorporates direct surgeon and administrator feedback into its total product ecosystem to meet the needs of major US hospital systems. Additionally, clinical and human-centered design experts will assist Vicarious Surgical to further enhance product design, helping ensure readiness for streamlined adoption upon FDA Approval.\n<\/p>\n

\nFor a full replay of the Vicarious Surgical Beta 2 Demonstration Day event please go to the Events<\/i> tab of the investor relations section of the Company\u2019s website, https:\/\/investor.vicarioussurgical.com<\/a>.\n<\/p>\n

\nAbout Vicarious Surgical<\/b>\n<\/p>\n

\nFounded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company\u2019s novel surgical approach uses proprietary human-like surgical robots to transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla\u2019s Khosla Ventures, Innovation Endeavors, Jerry Yang\u2019s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang\u2019s E15 VC. The Company is headquartered in Waltham, Massachusetts. Learn more at www.vicarioussurgical.com<\/a>.\n<\/p>\n

\nAbout University Hospitals<\/b>\n<\/p>\n

\nFounded in 1866, University Hospitals serves the needs of patients through an integrated network of more than 20 hospitals (including five joint ventures), more than 50 health centers and outpatient facilities, and over 200 physician offices in 16 counties throughout northern Ohio. The system\u2019s flagship quaternary care, academic medical center, University Hospitals Cleveland Medical Center, is affiliated with Case Western Reserve University School of Medicine, Northeast Ohio Medical University, Oxford University and the Technion Israel Institute of Technology. The main campus also includes the UH Rainbow Babies & Children\u2019s Hospital, ranked among the top children\u2019s hospitals in the nation; UH MacDonald Women\u2019s Hospital, Ohio\u2019s only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, with more than 3,000 active clinical trials and research studies underway. UH Cleveland Medical Center is perennially among the highest performers in national ranking surveys, including \u201cAmerica\u2019s Best Hospitals\u201d from U.S. News & World Report. UH is also home to 19 Clinical Care Delivery and Research Institutes. UH is one of the largest employers in Northeast Ohio with more than 30,000 employees. Follow UH on LinkedIn, Facebook and Twitter. For more information, visit UHhospitals.org<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Inquiries<\/b>
Abby Mayo for Matter Health
\n
media@vicarioussurgical.com<\/a>\n<\/p>\n

\nInvestor Contact<\/b>
Kaitlyn Brosco
\n
Vicarious Surgical
\n
Kbrosco@vicarioussurgical.com<\/a>\n<\/p>\n

\nMarissa Bych
\n
Gilmartin Group
\n
Marissa@gilmartinir.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

WALTHAM, Mass.–(BUSINESS WIRE)–Vicarious Surgical Inc. (\u201cVicarious Surgical\u201d or the \u201cCompany\u201d), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, hosted the first public demonstration of its Beta 2 surgical robotic platform on December 6, 2022, highlighting the latest evolution of its differentiated technology and showcasing recent cadaveric testing. Supporting … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52317","6":"format-standard","7":"category-industry"},"yoast_head":"\nVicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass.–(BUSINESS WIRE)–Vicarious Surgical Inc. (\u201cVicarious Surgical\u201d or the \u201cCompany\u201d), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, hosted the first public demonstration of its Beta 2 surgical robotic platform on December 6, 2022, highlighting the latest evolution of its differentiated technology and showcasing recent cadaveric testing. Supporting ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-23T00:02:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221222005570\/en\/1672307\/21\/download.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Vicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System\",\"datePublished\":\"2022-12-23T00:02:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\\\/\"},\"wordCount\":993,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221222005570\\\/en\\\/1672307\\\/21\\\/download.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\\\/\",\"name\":\"Vicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221222005570\\\/en\\\/1672307\\\/21\\\/download.jpg\",\"datePublished\":\"2022-12-23T00:02:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221222005570\\\/en\\\/1672307\\\/21\\\/download.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221222005570\\\/en\\\/1672307\\\/21\\\/download.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/","og_locale":"en_US","og_type":"article","og_title":"Vicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System - Pharma Trend","og_description":"WALTHAM, Mass.–(BUSINESS WIRE)–Vicarious Surgical Inc. (\u201cVicarious Surgical\u201d or the \u201cCompany\u201d), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, hosted the first public demonstration of its Beta 2 surgical robotic platform on December 6, 2022, highlighting the latest evolution of its differentiated technology and showcasing recent cadaveric testing. Supporting ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-23T00:02:32+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221222005570\/en\/1672307\/21\/download.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Vicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System","datePublished":"2022-12-23T00:02:32+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/"},"wordCount":993,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221222005570\/en\/1672307\/21\/download.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/","url":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/","name":"Vicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221222005570\/en\/1672307\/21\/download.jpg","datePublished":"2022-12-23T00:02:32+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221222005570\/en\/1672307\/21\/download.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221222005570\/en\/1672307\/21\/download.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/vicarious-surgical-completes-public-demonstration-of-beta-2-surgical-robotic-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Vicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52317"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52317\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}